SharecloseShare pageCopy linkAbout sharing
Cancer specialists say a new form of personalised treatment is producing promising results in adults with leukaemia.
The treatment, known as CAR-T, involves reprogramming the patient’s own immune system to attack their cancer.
The team at University College London say the “transformative” treatment may offer hope where others have failed.
Claire Evans believes she was “very lucky” to have the therapy two years ago; she is still in remission.
“I don’t think I’d be here if I hadn’t had CAR-T,” says Claire, from Hampshire. “I was very, very lucky that the trial was there at the time.
“If the CAR-T option hadn’t been available, I would have had, probably, a finite amount of time left.”
<div data-component="text-block" class="ssrcss-uf6wea-RichTextComponentWrapper